0000899866-16-000391.txt : 20161213 0000899866-16-000391.hdr.sgml : 20161213 20161213182406 ACCESSION NUMBER: 0000899866-16-000391 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161212 FILED AS OF DATE: 20161213 DATE AS OF CHANGE: 20161213 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALEXION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000899866 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133648318 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 2032722596 MAIL ADDRESS: STREET 1: 100 COLLEGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06510 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moriarty John B CENTRAL INDEX KEY: 0001564621 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27756 FILM NUMBER: 162049946 MAIL ADDRESS: STREET 1: ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 4 1 wf-form4_148167143337012.xml FORM 4 X0306 4 2016-12-12 0 0000899866 ALEXION PHARMACEUTICALS INC ALXN 0001564621 Moriarty John B C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510 0 1 0 0 EVP & General Counsel Common Stock, par value $.0001 per share 2016-12-12 4 S 0 1044 118.61 D 50181 D This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $118.00 - $118.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Michael Greco, Attorney-in-Fact for John B. Moriarty 2016-12-13